Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women
- 107 Downloads
Mammographic breast and bone mineral densities (BMD) have been associated with luteal phase hormone concentrations in premenopausal women. We assessed the associations of breast and bone densities with follicular phase hormones and sex hormone binding globulin (SHBG) in premenopausal women, given that follicular phase hormones have been shown to be positively associated with premenopausal breast cancer risk.
One hundred and ninety-two 40–45-year-old women provided a spot urine and/or blood sample during the follicular phase. Hormone and SHBG concentrations, and bone density were measured and routine mammograms were accessed and digitized to obtain breast density measures. Regression models were fit to assess the associations between hormones and SHBG, and breast and bone densities.
Positive associations were observed between percent breast density and SHBG (p trend = 0.02), as well as estradiol (p trend = 0.08), after controlling for body mass index (BMI), number of pregnancies, and breast feeding history. In addition, a statistically significant inverse association was observed between total testosterone and head BMD (p trend = 0.01), after controlling for BMI.
Associations were observed between breast and bone densities, and serum hormone concentrations during the follicular phase of the menstrual cycle.
KeywordsEstrogens Androgens Mammographic density Bone mineral density Premenopausal women
We wish to thank Kelly Ehrlich, Kathy Plant, and the GH Center for Health Studies for screening interviews, clinic visits, and study coordination and all the study participants. This work was supported by the National Institute of Health (R01CA97366) and the FHCRC Center Interdisciplinary Funds.
- 3.Holt VL, Jenkins J (2000) Endometriosis. In Goldman M, Hatch M (eds) Women and health. Academic Press, San Diego, CA, pp 226–235Google Scholar
- 6.Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE (2006) Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 15(5):972–978. doi: 10.1158/1055-9965.EPI-05-0848 PubMedCrossRefGoogle Scholar
- 17.Atkinson C, Newton KM, Stanczyk FZ, Westerlind KC, Li L, Lampe JW (2008) Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. Cancer Causes Control 19(10):1085–1093. doi: 10.1007/s10552-008-9172-3 PubMedCrossRefGoogle Scholar
- 18.Goebelsmann U, Bernstein GS, Gale JA, Kletzky OA, Nakamura RM, Coulson AH et al (1979) Serum gonadotropin, testosterone, estradiol, estrone levels prior to, following bilateral vasectomy. In: Lepow IH, Crozier R (eds) Vasectomy: immunologic and pathophysiologic effects in animals and man. Academic Press, New York, p 165Google Scholar
- 22.Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A et al (2002) Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1065–1071PubMedGoogle Scholar
- 24.Qin L, Chen J, Ge C, Ma H, Zhang W, Xiao Y et al. (1999) Analysis of bone mineral density and relevant factors in 781 healthy people aged 15 to 50. Zhonghua Yu Fang Yi Xue Za Zhi 33:282–285Google Scholar
- 25.Finkelstein JS, Lee ML, Sowers M, Ettinger B, Neer RM, Kelsey JL et al (2002) Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 87(7):3057–3067. doi: 10.1210/jc.87.7.3057 PubMedCrossRefGoogle Scholar
- 28.Fortunati N, Fissore F, Fazzari A, Piovano F, Catalano MG, Becchis M et al (1999) Induction of camp in breast cancer cells is mediated by foetal calf serum (fcs) and sex hormone-binding globulin (SHBG). J Steroid Biochem Mol Biol 70:73–80. doi: 10.1016/S0960-0760(99)00092-8 PubMedCrossRefGoogle Scholar
- 30.Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ et al (2000) Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16 alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 11:635–640. doi: 10.1097/00001648-200011000-00004 PubMedCrossRefGoogle Scholar
- 32.Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM, Cauley JA et al (2003) The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int 14:44–52. doi: 10.1007/s00198-002-1307-x PubMedCrossRefGoogle Scholar
- 37.Ahmad N, Pollard TM, Unwin N (2002) The optimal timing of blood collection during the menstrual cycle for the assessment of endogenous sex hormones: can interindividual differences in levels over the whole cycle be assessed on a single day? Cancer Epidemiol Biomarkers Prev 11(1):147–151PubMedGoogle Scholar